Legend Biotech Corp Weighted Average Fair Value At Measurement Date Share Options Granted
Legend Biotech Corp (LEGN) had Weighted Average Fair Value At Measurement Date Share Options Granted of $4.80 million as of 2023-12-31, per its 20-F filed 2024-03-19.
Discontinued › Notes
ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted · last filed 2024-03-19
- 2023-12-31: Weighted Average Fair Value At Measurement Date Share Options Granted $4.80M.
- 2022-12-31: Weighted Average Fair Value At Measurement Date Share Options Granted $27.20M.
- 2021-12-31: Weighted Average Fair Value At Measurement Date Share Options Granted $5.70M.
- 2020-12-31: Weighted Average Fair Value At Measurement Date Share Options Granted $6.70M; Weighted Average Fair Value At Measurement Date Share Options Granted as first filed $6.67M.
| Period end | Weighted Average Fair Value At Measurement Date Share Options Granted | Weighted Average Fair Value At Measurement Date Share Options Granted as first filed |
|---|---|---|
| 2023-12-31 | $4.80M 20-F · filed 2024-03-19 | |
| 2022-12-31 | $27.20M 20-F · filed 2024-03-19 | |
| 2021-12-31 | $5.70M 20-F · filed 2024-03-19 | |
| 2020-12-31 | $6.70M 20-F · filed 2023-03-30 | $6.67M 20-F · filed 2021-04-02 |
| 2019-12-31 | $1.10M 20-F/A · filed 2023-02-17 | $1.10M 20-F · filed 2021-04-02 |
| 2018-12-31 | $4.33M 20-F · filed 2021-04-02 |